From understanding diseases to drug design: can artificial intelligence bridge the gap?

AC Pushkaran, AA Arabi - Artificial Intelligence Review, 2024 - Springer
Artificial intelligence (AI) has emerged as a transformative technology with significant
potential to revolutionize disease understanding and drug design in healthcare. AI serves as …

[HTML][HTML] Role of Artificial Intelligence in Revolutionizing Drug Discovery

AU Rehman, M Li, B Wu, Y Ali, S Rasheed… - Fundamental …, 2024 - Elsevier
The application of artificial intelligence (AI) in medicine, particularly through machine
learning (ML), marked a significant progression in drug discovery. AI acts as a powerful …

Multi-Target In-Silico modeling strategies to discover novel angiotensin converting enzyme and neprilysin dual inhibitors

SK Shah, DD Chaple, VH Masand, RD Jawarkar… - Scientific Reports, 2024 - nature.com
Cardiovascular diseases, including heart failure, stroke, and hypertension, affect 608 million
people worldwide and cause 32% of deaths. Combination therapy is required in 60% of …

Polypill versus medication monotherapy in the prevention of cardiovascular diseases in Iran: An economic evaluation study

R Ravangard, M Ghanbari, A Attar… - Health Science …, 2024 - Wiley Online Library
Abstract Background and Aims Cardiovascular diseases (CVDs) are one of the major
diseases in developing and developed countries and have high prevalence and mortality …

[PDF][PDF] Serial or Simultaneous? Possible Attack Strategies with an Arsenal of Attack Tools.

Y Giat, I Nowik - ICORES, 2024 - scitepress.org
In various fields such as medicine, management, cyber operations, and military strategy, the
choice between sequential and parallel strategies is pivotal in achieving objectives, be it …

Diuretika bei arterieller Hypertonie

D Essigke - Nephrologie aktuell, 2024 - thieme-connect.com
Seit Jahrzehnten sind Diuretika bei der antihypertensiven Therapie nicht wegzudenken und
werden millionenfach verordnet. In den letzten Jahren wurden verschiedentliche Studien …